OncoGenex Pharmaceuticals, Inc. (OGXI) Reports Q4 Loss of $0.28

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q4 EPS of ($0.28), versus consensus of ($0.50).

For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
• S&P 500 may pull back before midterms, but Citi says buy the dip
• Vireo Growth completes acquisition of C21 Investments